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Summary
Amyotrophic lateral sclerosis (ALS) with bulbar dysfunction affects the motor neurons 
responsible for controlling the muscles in the jaw, face, soft palate, pharynx, larynx and 
tongue. This cross- sectional study aimed to determine the functional limitation of the 
jaw in patients with ALS and bulbar dysfunction who had upper motor neuron (UMN), 
lower motor neuron (LMN) or balanced involvement. One hundred and fifty- three pa-
tients with ALS and 23 controls were included. All participants answered using the 8- 
item Jaw Functional Limitation Scale (JFLS- 8). Patients with ALS were grouped by 
neurologic examination as follows: non- bulbar ALS, bulbar UMN- predominant ALS; 
bulbar LMN- predominant ALS; and bulbar balanced (UMN + LMN) ALS. Jaw limitation 
between the different groups was compared using the Kruskal- Wallis test. Patients 
with non- bulbar ALS had similar mandibular limitations to healthy participants. Only 
patients with balanced UMN and LMN bulbar manifestations reported greater difficul-
ties in chewing soft food or in jaw mobility compared to the non- bulbar ALS group. 
Patients with bulbar involvement also had greater difficulties in chewing tough food or 
chicken and in swallowing and talking compared to the non- bulbar group, regardless 
of whether UMN or LMN predominant. No significant differences were found be-
tween the groups in smiling and yawning difficulties. Bulbar involvement in patients 
with ALS is associated with functional limitation of the masticatory system. However, 
balanced bulbar UMN and LMN involvement is associated with the worst impairments 
in chewing soft food and in opening the jaw widely.
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Amyotrophic lateral sclerosis (ALS) is a motor neuron disease 
characterised by progressive degeneration of motor neurons in 
the brain, brainstem and spinal cord. Affected individuals show 
significant variation in the locus of disease onset, presentation 
at diagnosis and rate of progression.1 Incidence rates for ALS are 
approximately 1.4 and 2.1 per 100 000 person/year in Catalonia 
and Europe, respectively.2,3 Sufferers develop progressive wasting 
and weakness of limb, bulbar and respiratory muscles and die on 
average within 3 years from symptom onset, usually from respira-
tory failure; however, roughly 10% of patients with ALS survive for 
ten or more years.4 The mean age of onset for sporadic ALS ranges 
from 55 to 65 years, with a median age of onset of 64 years.5 
The diagnosis of ALS is based on the El Escorial and Airlie House 
Diagnostic Criteria.6
Approximately two- thirds of patients with a typical ALS disease 
pattern develop initial symptoms in the upper or lower extremities 
(limb or spinal onset), most commonly in distal muscles. The other 
third of patients have bulbar onset, usually starting with dysarthria, 
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but almost all demonstrate bulbar involvement at later stages. About 
5% of patients present with respiratory weakness without signifi-
cant limb or bulbar symptoms.7,8 In patients with bulbar dysfunction, 
upper motor neuron (UMN) involvement causes supranuclear symp-
toms that are also commonly referred to as pseudobulbar palsy. The 
clinical characteristics of pseudobulbar palsy are spasticity and hyper-
reflexia of the bulbar muscles (ie jaw, face, soft palate, pharynx, larynx 
and tongue), emotional lability (pathological laughing and crying) and 
a brisk jaw jerk. Degeneration of lower motor neuron (LMN), with 
involvement of the cranial nerve nuclei in the medulla oblongata and 
pons that innervate the bulbar muscles, results in a bulbar palsy with 
flaccid paresis, muscular atrophy and fasciculations and/or tongue 
fibrillations.7,9
Oro- facial function is an important contributor to an individ-
ual’s general health and quality of life. The masticatory system is 
responsible for complex biopsychosocial functions, where basic 
functions such as chewing, swallowing, eating and yawning man-
ifest simultaneously with emotional functions such as smiling, 
laughing, screaming and kissing. Functional limitation and disability 
can be measured with generic, disease- specific or organ- specific 
instruments. The 20- item Jaw Functional Limitation Scale (JFLS- 
20) is a reliable and valid organ- specific instrument for measuring 
limitations in mastication, jaw mobility and verbal and emotional 
expressions, together with a global functional limitation score. 
Global limitation can also be determined with a short version, the 
JFLS- 8. These scales have three subscales that cover mastication, 
vertical jaw mobility and emotional and verbal expressions. The 
properties of the JFLS- 8 scales are ideal for both research and pa-
tient evaluation when assessing global functional limitation of the 
jaw.10
Masticatory function includes phenomena such as bite force, 
mandibular mobility and masticatory performance11-13 and has 
been studied by assessing these phenomena in other neurological 
diseases.14-19 However, to the authors’ knowledge, functional lim-
itation of the masticatory system has not been assessed in a large 
sample of patients with ALS. The main objective of this study was 
to determine the effect of bulbar involvement on functional lim-
itation of the masticatory system in patients with ALS. This study 
also aimed to compare the functional limitation of the masticatory 
system between patients with ALS and a pseudobulbar palsy (UMN 
involvement) and patients with ALS and a bulbar palsy (LMN in-
volvement). The working hypothesis was that bulbar involvement 
would cause functional limitation of the masticatory system in pa-
tients with ALS.
ƑՊ |Պ$!"	$	"
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In this cross- sectional study, 153 patients diagnosed with ALS 
according to the revised El Escorial and Airlie House Diagnostic 
Criteria at the Motor Neuron Disease Unit of the Bellvitge 
University Hospital were selected. A control group was included 
that comprised 23 participants recruited from the families or car-
egivers of patients with ALS and other age- and gender- matched 
people. All subjects participated in a previous investigation.20 
Patients were excluded if they could not be evaluated because of 
their clinical condition or sensory deficits. All participants were 
fully informed and signed an informed consent form approved by 
Bellvitge University Hospital Ethics Committee (Code PR260/15), 
and all experiments were carried out in accordance with the princi-
ples of the Helsinki Declaration.
ƑĺƑՊ|Պ"Ŋu;Ѵ-|;71_-u-1|;ubv|b1v
Bulbar dysfunction involvement was determined as UMN, LMN or 
balanced (UMN + LMN) based on neurologic examination by a neurol-
ogist, using upper motor signs (ie brisk jaw jerk, tongue spasticity and 
spastic dysarthria) and lower motor signs (ie tongue wasting, tongue 
fasciculations and flaccid dysarthria).21
ƑĺƒՊ|Պm1|bom-Ѵf-Ѵblb|-|bomvv1-Ѵ;
Functional limitation of the masticatory system was assessed using 
the JFLS- 8.10 This scale evaluates 8 items: (1) chew tough food, (2) 
chew chicken (eg prepared in oven), (3) eat soft food requiring no 
chewing (eg mashed potatoes, apple sauce, pudding, pureed food), 
(4) open wide enough to drink from a cup, (5) swallow, (6) yawn, (7) 
talk and (8) smile. The participants rated the level of limitation for 
each item during last month using a 0- 10 numerical rating scale, 
with 0 corresponding to “no limitation” and 10 corresponding to 
“maximal limitation.” The examiner interviewed each participant 
orally asking all JFLS items. The patient’s caregiver helped answer-
ing in case the patient had some difficulties. Questionnaires were 
filled when the patients were attended by the ALS unit multidisci-
plinary team for a check- up. The median time elapsed between the 
first symptom onset and the questionnaire was 31 months, and the 
median time elapsed between the diagnostic and the questionnaire 
was 16 months (Table 1).
ƑĺƓՊ|Պ	-|--m-Ѵvbv
Participants were distributed into 1 of the 5 groups. The con-
trol group included 23 healthy participants, and the 153 patients 
with ALS were grouped as those with non- bulbar ALS, bulbar 
UMN- predominant ALS, bulbar LMN- predominant ALS and bulbar 
balanced ALS (with both UMN and LMN) groups. Items from the 
same subscale of the JFLS- 8 with similar results were averaged, 
such as the chew tough food and chew chicken items, the swal-
low and talk items, or the yawn and smile items. The degree of 
jaw limitation for each subscale and for the eight items was com-
pared between the different groups using the Kruskal- Wallis 
test with adjustment for pairwise comparisons. All analyses 
were performed in IBM SPSS Statistics, version 24.0 (IBM Corp., 
Armonk, NY, USA), and PŊ-Ѵ;vƽĺƏƔ;u;1omvb7;u;7v|-|bv|b1-ѴѴ
significant.
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This study included 153 patients with ALS (mean age 62 years, SD 
12 years; 46% women) and 23 controls (mean age 51 years, SD 
12 years; 56% women). Patients with ALS were assigned to one of 
the four groups according to bulbar involvement, and their charac-
teristics are summarised in Table 1. In total, 10% of patients with ALS 
received parotid botulin toxin injections, 32% required non- invasive 
ventilation, and although 76% had normal eating habits, 11% re-
quired supplemental tube feeding and 12% required either probe or 
oral feeding.
ƒĺƑՊ|Պolr-ubvomo=|_;0Ѵ0-u-m7momŊ
bulbar groups
Two of the three mastication subscale items of the JFLS- 8, chew 
tough food and chew chicken, were averaged because the results were 
similar. Although patients in the non- bulbar ALS group were similar to 
controls on the chewing measures, patients in the bulbar ALS groups 
had greater difficulties in chewing tough food or chicken compared to 
those in the non- bulbar group, regardless of the motor neuron affected 
(Figure 1). However, only patients in the balanced bulbar ALS group re-
ported greater difficulties in chewing soft food compared with the non- 
bulbar ALS group (Figure 2). Patients in the balanced bulbar ALS group 
reported greater difficulties in opening their mouths wide enough to 
drink from a cup compared to those in the non- bulbar group (Figure 3).
Although patients in the non- bulbar ALS group had no significant 
differences in swallow and talk difficulties compared with the control 
group, patients in the ALS groups with bulbar involvement had greater 
swallow and talk difficulties compared with the non- bulbar group re-
gardless of the motor neuron affected (Figure 4). However, there were 
no significant differences in smiling and yawning difficulties between 
any of the groups (Figure 5).
Considering all items of the three subscales, patients without bul-
bar involvement in ALS had similarly low functional jaw difficulties 
$ ƐՊCharacteristics of healthy and patients with amyotrophic lateral sclerosis
Characteristics
Healthy 
(n = 23)
ALS Patients (n = 157)
P- value 
between each 
subgroupa
No Bulbar 
affectation 
(n = 47)
Bulbar UMN- 
predominant 
(n = 28)
Bulbar LMN- 
predominant 
(n = 18)
Balanced bulbar 
UMN and LMN 
(n = 60)
Sex (% of Male) 44 64 36 56 53 NS
Mean age (years) 51 62 62 69 60 <.0005
Median time elapsed since 
symptom onset (months)
35.4 35.0 33.2 24.4 .015
Median time elapsed since ALS 
diagnosis (months)
18.8 19 12.5 13.3 .554
Botulinum toxin (%) 2.1 3.6 16.7 16.9 .034
Non- invasive ventilation (%) 36.2 25 55.6 25 .074
Oral feeding (%) 100 92.9 83.3 81.7 .015
Use of tube feeding (%) 6.4 14.3 50 31.7 <.0005
aChi- squared test or Kruskal- Wallis test.
 &! ƐՊMeans and standard 
deviation of limitation score of chewing 
tough food and chicken. *P ƽ .05; **P ƽ .01; 
***P ƽ .001 Kruskal- Wallis test and pairwise 
comparisons of different groups 8
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compared to healthy participants. By contrast, patients with bulbar 
involvement in ALS had greater functional jaw difficulties compared 
to those without bulbar involvement, regardless of the motor neuron 
affected (Figure 6).
ƓՊ |Պ	"&""
The results of this study indicate that bulbar involvement was sig-
nificantly associated with perceived functional limitation of the 
 &! ƑՊMeans and standard 
deviation of limitation score of chewing 
soft food. **P ƽ .01; ***P ƽ .001 Kruskal- 
Wallis test and pairwise comparisons of 
different groups
 &! ƒՊMeans and standard 
deviation of limitation score of jaw mobility. 
*P ƽ .05 Kruskal- Wallis test and pairwise 
comparisons of different groups
 &! ƓՊMeans and standard 
deviation of limitation score of swallowing 
and talking. **P ƽ .01; ***P ƽ .001 Kruskal- 
Wallis test and pairwise comparisons of 
different groups
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masticatory system in patients with ALS. In the bulbar group, the 
greatest impairment was seen in those with balanced UMN and LMN 
diseases, as evidenced primarily by difficulties in chewing soft food 
and opening the jaw widely, as well as difficulties in chewing tough 
food and chicken, swallowing and talking.
When patients have been grouped by symptom type at onset, 
aspects of masticatory function, like bite force and range of jaw mo-
bility, were objectively shown to be reduced in bulbar- onset groups 
compared with spinal or respiratory onset groups.20 Moreover, the 
bulbar- onset group showed more severe oro- facial impairment than 
the spinal- onset group assessed with the Nordic Oro- facial Test- 
Screening.21 Results of the present study suggest that masticatory 
function is also affected when the involvement of the bulbar region 
occurs during the evolution of the disease. This is consistent with the 
fact that the bulbar target damages neurons responsible for controlling 
facial, masticatory, pharyngeal and laryngeal muscles. There are dif-
ferences in neurological symptoms between UMN and LMN involve-
ment.8 Emotional lability, nasal speech, nasal regurgitation, excessive 
saliva, slow tongue and brisk jaw jerk and facial reflexes are charac-
teristics of UMN. Slurred speech, difficulty in swallowing, excessive 
saliva, small and fasciculating tongue are characteristics for LMN.8 The 
difficulties in masticatory function are related to upper motor neuron 
signs as tongue spasticity or to lower motor neuron signs as tongue 
atrophy. Despite the neurological differences between patients with 
upper or lower motor neuron involvement, no differences in mastica-
tion, jaw mobility or verbal and emotional expression were observed. 
However, when both motor neurons were affected, there was a 
greater degree of functional limitation in these measures.
Although the jaw mobility is reduced in balanced bulbar UMN and 
LMN ALS, yawning was not affected in this study. It is known that 
excessive yawning occurs in a substantial number of patients with ALS 
specially in those with a bulbar onset.8,22 Probably this could be related 
to the inhibition of normal control mechanisms of emotions, which 
would mean that neurological paths controlling voluntary mandibular 
opening and yawning are different. However, to date, no physiological 
significance has been associated with yawning, and the neural path-
ways underlying it are not known.23 Moreover, even though patients 
with bulbar symptoms experience facial weakness affecting the lower 
half of the face, no patient in this study reported difficulty smiling.
Amyotrophic lateral sclerosis (ALS) is a low- prevalent disease, and 
therefore, it should not be considered as a first- line differential diag-
nosis in patients with temporomandibular disorders. Nevertheless, 
 &! ƔՊMeans and standard 
deviation of limitation score of yawning 
and smiling. P > .05 Kruskal- Wallis test and 
pairwise comparisons of different groups
 &! ѵՊMeans and standard 
deviation of JFLS- 8 global limitation score. 
**P ƽ .01; ***P ƽ .001 Kruskal- Wallis test 
and pairwise comparisons of different 
groups
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as most of the bulbar- onset patients reported the first symptoms in 
the oro- facial region, dentists should keep in mind this possibility in 
those situations in which, in a patient with apparent symptoms of 
temporomandibular disorders, there are incongruous signs or symp-
toms.24 These signs and symptoms may include difficulty in mastica-
tion, speech or swallowing due to an impairment in tongue control or a 
weakness in masticatory muscles, and difficulty in mandibular mobility 
not attributable to muscular or articular pain or disc displacement.7,8
Mandibular mobility and/or bite force are also reduced in pa-
tients with other neuromuscular diseases, including spinal muscular 
atrophy,14-16 bulbar myasthenia gravis17,18 and Duchenne muscular 
dystrophy.19 A reduced ability to open the mouth may hinder oral hy-
giene and perhaps even the efficacy of non- invasive ventilation. To 
minimise these complications, especially in patients with bulbar onset, 
an effective physiotherapy programme of active exercises is needed 
to slow the rate of reduction in mouth opening.19 The physiotherapy 
programme could consist of moderate- load and moderate- intensity 
resistance and stretching exercise programme to improve mandibu-
lar mobility.25 Moreover, the dentist could also manage ALS patients 
to avoid traumatic lesions in the lips, cheeks or tongue due to self- 
biting.20 Recommendations for dental care in patients with ALS also 
include a regular oral maintenance care to maintain oral health and 
avoid dental disease, as well as counselling for dietary modifications.26 
Symptoms of dysphagia may occur at any time in the act of swallow-
ing. Patients may report failure to chew or intolerance to texture in 
the oral preparatory phase and pocketing of food in the oral phase.27 
Recommendations to improve or mitigate swallowing function include 
compensatory manoeuvres, behavioural strategies, sensory tricks and 
dietary modifications such as mechanically altered food, thickened liq-
uids, soft diet or liquidise food.26 Consequently, dentists should also 
be included in the multidisciplinary team to improve the quality of life 
of patients with ALS.
The sample of this study was representative to the population of 
Catalonia, corresponding to 30% of the approximate 451 patients with 
ALS diagnosed among the 7 500 000 inhabitants.2 However, the small 
sample size and recruitment method for the control group are poten-
tial limitations. Nevertheless, the prevalence of TMD and the range 
of mandibular motion in the control group were comparable to those 
reported in other studies.28,29
In conclusion, bulbar involvement in patients with ALS is associated 
with functional limitation of the masticatory system. However, bal-
anced bulbar UMN and LMN involvement is associated with the worst 
impairments, affecting soft food chewing and opening the jaw widely.
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